Μετάφραση και ανάλυση λέξεων από την τεχνητή νοημοσύνη ChatGPT
Σε αυτήν τη σελίδα μπορείτε να λάβετε μια λεπτομερή ανάλυση μιας λέξης ή μιας φράσης, η οποία δημιουργήθηκε χρησιμοποιώντας το ChatGPT, την καλύτερη τεχνολογία τεχνητής νοημοσύνης μέχρι σήμερα:
- πώς χρησιμοποιείται η λέξη
- συχνότητα χρήσης
- χρησιμοποιείται πιο συχνά στον προφορικό ή γραπτό λόγο
- επιλογές μετάφρασης λέξεων
- παραδείγματα χρήσης (πολλές φράσεις με μετάφραση)
- ετυμολογία
extrapyramidal hyperkinesia - translation to ρωσικά
медицина
экстрапирамидный гиперкинез
![The [[basal ganglia]] are involved in hyperkinesia.](https://commons.wikimedia.org/wiki/Special:FilePath/Basal ganglia and related structures (2).svg?width=200 "The [[basal ganglia]] are involved in hyperkinesia.")
![[[Samuel Alexander Kinnier Wilson]], the neurologist most known for his description of what came to be known as [[Wilson's disease]].](https://commons.wikimedia.org/wiki/Special:FilePath/Samuel Alexander Kinnier Wilson.jpg?width=200 "[[Samuel Alexander Kinnier Wilson]], the neurologist most known for his description of what came to be known as [[Wilson's disease]].")
[haipəkai|'ni:ziə-{haipəkai}'ni:sis]
общая лексика
гиперкинез
медицина
гиперкинезия
существительное
медицина
гиперкинез
повышенная мышечная деятельность
медицина
гиперкинетический
Ορισμός
Βικιπαίδεια
Extrapyramidal symptoms (EPS) are symptoms that are archetypically associated with the extrapyramidal system of the brain's cerebral cortex. When such symptoms are caused by medications or other drugs, they are also known as extrapyramidal side effects (EPSE). The symptoms can be acute (short-term) or chronic (long-term). They include movement dysfunction such as dystonia (continuous spasms and muscle contractions), akathisia (may manifest as motor restlessness), parkinsonism characteristic symptoms such as rigidity, bradykinesia (slowness of movement), tremor, and tardive dyskinesia (irregular, jerky movements). Extrapyramidal symptoms are a reason why subjects drop out of clinical trials of antipsychotics; of the 213 (14.6%) subjects that dropped out of one of the largest clinical trials of antipsychotics (the CATIE trial (Clinical Antipsychotic Trials for Intervention Effectiveness), which included 1460 randomized subjects), 58 (27.2%) of those discontinuations were due to EPS.
